Journal of Tropical Medicine / 2012 / Article / Tab 3 / Clinical Study
Efficacy and Tolerability of Malartin and Sulphadoxine-Pyrimethamine Combination against Uncomplicated Falciparum Malaria in Dibanda, Southwest Cameroon Table 3 Variation in geometric mean parasite density of patients attending CAMEF during the in vivo study, 2007-2008 by sex, age group, and social class during followup after treatment with Malartin and SP.
Characteristic GMPD Category Day 0 Day 3 Day 7 Day 14 Sex Male
𝑁
=
7
4
4599 (1014–04000) 2199 (382–5846) 900 (207–4938) 808 (280–3749) Female
𝑁
=
1
0
0
4154 (1000–42974) 1904 (196–10667) 641 (143–4525) 626 (167–3574) Level of significance
𝐹
=
1
.
4
1
8
𝑃
=
0
.
2
3
5
𝐹
=
0
.
6
2
5
𝑃
=
0
.
4
3
0
𝐹
=
4
.
8
2
6
𝑃
=
0
.
0
3
0
𝐹
=
0
.
7
6
4
𝑃
=
0
.
3
8
6
Age group (years) 1–5 (
𝑁
=
4
9
) 6517 (1087–48511) 2189 (196–5846) 788 (181–3629) 751 (170–3749) 6–10 (
𝑁
=
3
3
) 3820 (1067–104000) 1652 (203–7719) 608 (182–1920) 604 (475–776) 11–15 (
𝑁
=
2
4
) 4054 (1200–18316) 2424 (333–7385) 832 (207–2913) 613 (167–2222) >15 (
𝑁
=
6
8
) 3524 (1000–36596) 1975 (218–10667) 730 (143–4938) 692 (150–3176) Level of significance
𝐹
=
3
.
6
6
7
𝑃
=
0
.
0
1
4
𝐹
=
1
.
2
3
2
𝑃
=
0
.
3
0
0
𝐹
=
0
.
7
4
0
𝑃
=
0
.
5
4
0
𝐹
=
1
.
1
4
3
𝑃
=
0
.
3
4
2
Social class Poor class (
𝑁
=
1
3
6
) 4495 (1000–48511) 2021 (203–10667) 727 (143–4938) 854 (167–3749) Middle class (
𝑁
=
3
2
) 4238 (1014–104000) 2239 (196–15846) 838 (385–2939) 746 (350–3176) Rich class (
𝑁
=
0
6
) 2193 (1023–5500) 822 (406–2016) 353 (353–353) 0 Level of significance
𝐹
=
0
.
7
9
3
𝑃
=
0
.
4
5
4
𝐹
=
1
.
3
1
5
𝑃
=
0
.
2
7
2
𝐹
=
0
.
2
8
2
𝑃
=
0
.
7
5
5
𝐹
=
0
.
2
3
4
𝑃
=
0
.
7
9
2
